UK markets closed
NIKKEI 225
37,628.48 -831.60 (-2.16%) HANG SENG
17,284.54 +83.27 (+0.48%) CRUDE OIL
82.57 -0.24 (-0.29%) GOLD FUTURES
2,341.70 +3.30 (+0.14%) DOW
38,002.77 -458.15 (-1.19%) Bitcoin GBP
51,492.36 -211.52 (-0.41%)
Zealand Pharma A/S (22Z.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 04:19PM CEST. Market open.
Currency in EUR
Valuation measures4
| Market cap (intra-day) | 5.23B |
| Enterprise value | 5.02B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 104.61 |
| Price/book (mrq) | 24.77 |
| Enterprise value/revenue | 14.65 |
| Enterprise value/EBITDA | -7.62 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.67 |
| 52-week change 3 | 181.85% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 103.40 |
| 52-week low 3 | 28.60 |
| 50-day moving average 3 | 84.78 |
| 200-day moving average 3 | 53.77 |
Share statistics
| Avg vol (3-month) 3 | 536 |
| Avg vol (10-day) 3 | 343 |
| Shares outstanding 5 | 62.27M |
| Implied shares outstanding 6 | 63.2M |
| Float 8 | 46.05M |
| % held by insiders 1 | 0.16% |
| % held by institutions 1 | 57.95% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in DKK.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -205.30% |
| Operating margin (ttm) | -1,043.37% |
Management effectiveness
| Return on assets (ttm) | -19.93% |
| Return on equity (ttm) | -58.43% |
Income statement
| Revenue (ttm) | 342.79M |
| Revenue per share (ttm) | 6.06 |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -554.72M |
| Net income avi to common (ttm) | -703.74M |
| Diluted EPS (ttm) | -1.67 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.63B |
| Total cash per share (mrq) | 27.97 |
| Total debt (mrq) | 119.23M |
| Total debt/equity (mrq) | 7.49% |
| Current ratio (mrq) | 6.25 |
| Book value per share (mrq) | 27.28 |
Cash flow statement
| Operating cash flow (ttm) | -425.67M |
| Levered free cash flow (ttm) | -228.98M |
© 2024 Yahoo. All rights reserved.